Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Phencyclidine
100%
Cognitive Impairment
100%
Cognitive Deficits
100%
Schizophrenia
100%
Molecular Predictors
50%
NR2 Subunit
50%
NR1 Subunit
50%
NMDA Subunits
50%
Targeted Knockout
50%
Transgenic Animals
50%
Knockout Animals
50%
Preclinical Assays
50%
Patient Recovery
50%
Hippocampus
50%
N-methyl-D-aspartate Receptor (NMDAR)
50%
Spatial Memory Task
50%
Etiology
50%
Behavioral Effects
50%
Pharmacological Agents
50%
Schizophrenia Treatment
50%
Atypical Antipsychotics
50%
Gene Targeting
50%
Functional Outcome
50%
Glutamate
50%
Frontal Cortex
50%
Olanzapine
50%
C57BL
50%
Drug Action
50%
Antipsychotic Drugs
50%
Inpatient Treatment
50%
Abuser
50%
Neuroscience
Phencyclidine
100%
Cognitive Disorders
100%
Schizophrenia
50%
NMDA Receptor
25%
Treatment of Schizophrenia
25%
N-Methyl-D-Aspartic Acid
25%
Glutamic Acid
25%
Behavioral Effect
25%
Hippocampus
25%
Atypical Antipsychotic
25%
Olanzapine
25%
Frontal Lobe
25%
Behavior (Neuroscience)
25%
Receptor
25%
Spatial Memory
25%
Antipsychotic
25%
C57BL 6 Mouse
25%